Rocket Pharmaceuticals, Inc.
RCKT
$3.39
-$0.15-4.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -257.30M | -258.03M | -258.75M | -258.08M | -253.26M |
| Total Depreciation and Amortization | 10.32M | 10.11M | 9.38M | 8.95M | 8.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.04M | 35.60M | 35.96M | 30.71M | 30.25M |
| Change in Net Operating Assets | 5.14M | 3.65M | 3.69M | 26.30M | 17.53M |
| Cash from Operations | -203.80M | -208.66M | -209.72M | -192.12M | -197.17M |
| Capital Expenditure | -2.31M | -4.19M | -5.86M | -10.20M | -13.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.09M | 42.83M | 137.57M | 38.97M | 11.37M |
| Cash from Investing | 14.77M | 38.64M | 131.71M | 28.77M | -1.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 183.03M | 184.56M | 185.74M | 3.28M | 192.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 215.00K | -- | -- | -- | -- |
| Cash from Financing | 183.24M | 184.56M | 185.74M | 3.28M | 192.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.79M | 14.53M | 107.72M | -160.07M | -6.47M |